Rizwan Haq

12PUBLICATIONS
93CO-AUTHORS
GravimetricsMolecular targetsPredictive and prognostic markersRadiation therapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 22, 2026
Oncogenic Gα signaling requires AP-3-dependent recruitment to the endolysosomal compartment.

|Jun 02, 2026
Preclinical response of uveal melanomas to the velcrin compound, BAY 2666605.

|May 20, 2024
Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting.

Marco Ventin, Giulia Cattaneo, Shahrzad Arya

|May 01, 2024
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation.

Rona Yaeger, Meredith A McKean, Rizwan Haq

|Apr 29, 2024
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma.

Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino

|May 02, 2022
Adapted to Survive: Targeting Cancer Cells with BH3 Mimetics.

Joan Montero, Rizwan Haq

Pageof 2

Frequent Collaborators

2 joint publications

Mario L Suvà

2 joint publications

Elizabeth H Stover

2 joint publications

Catherine J Wu

2 joint publications

Michael R Clay